SEARCH

SEARCH BY CITATION

References

  • 1
    Hiruma M, Matsushita A, Kobayashi M, Ogawa H. One week pulse therapy with itraconazole (200 mg day−1) for onychomycosis. Evaluation of treatment results according to patient background. Mycoses 2001; 44: 8793.
  • 2
    Gupta AK, Lynde CW, Konnikov N. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis. J Am Acad Dermatol 2001; 44: 48591.
  • 3
    Faergemann J, Zehender H, Denouel J, Milleroux L. Levels of terbinafine in plasma, stratum corneum, dermisepidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once per day four weeks. Acta Derm Venereol 1993; 73: 3059.
  • 4
    Shuster S, Munro SC. Single dose treatment of fungal nail disease. Lancet 1992; 339: 1066.
  • 5
    Tosti A, Piraccini BM, Stinchi C, Venturo N. Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy. J Am Acad Dermatol 1996; 34: 595600.
  • 6
    Alpsoy E, Yilmaz E, Basaran E. Intermittent therapy with terbinafine for dermatophyte toe-onychomycosis: a new approach. J Dermatol 1996; 23: 25962.
  • 7
    Warshaw EM, Carver SM, Zielke GR, Ahmed DDF. Intermittent terbinafine for toenail onychomycosis: is it effective? Result of a randomized pilot trial. Arch Dermatol 2001; 137: 1253.
  • 8
    Sanmano B, Hiruma M, Mizoguchi M, Ogawa H. Combination therapy consisting of 1-week pulse of oral terbinafine plus topical application of terbinafine cream in the treatment of onychomycosis. J Dermatol Treat 2004; 15: 17.
  • 9
    Zaias N, Rebell G. The successful treatment of Trichophyton rubrum nail bet (distal subungual) onychomycosis with intermittent pulse-dosed terbinafine. Arch Dermatol 2004; 140: 6915.
  • 10
    Nakano N, Hiruma M, Shiraki Y, Chen X, Porgpermdee S, Ikeda S. Combination of pulse therapy with terbinafine tablets (500 mg day−1 for 1 week + following 3 weeks interval) and topical terbinafine cream for the treatment of dermatophyte onychomycosis: a pilot study. J Dermatol 2006; 33: 7538.
  • 11
    Darkes MJ, Scott LJ, Goa KL. Terbinafine: a review of its use in onychomycosis in adults. Am J Clin Dermatol 2003; 4: 3965.
  • 12
    Sergeev AY, Gupta AK. The scoring clinical index for onychomycosis (SCIO Index). Skin Therapy Lett 2002; 7: 67.
  • 13
    Scher RK. Onychomycosis: therapeutic update. J Am Acad Dermatol 1999; 40: 216.
  • 14
    Terbinafine study group. Clinical evaluation of terbinafine tablets on onychomycosis: a double-blind comparative trial in comparison with griseofulvin tablets. Nishinihon J Dermatol 1994; 56: 80925 (in Japanese).
  • 15
    Havu V, Brandt H, Heikkila H et al. A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis. Br J Dermatol 1997; 136: 2304.